Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-09

Clinical Trial Update: Cholecalciferol on Hemodialysis Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating cholecalciferol (vitamin D3) in hemodialysis patients with vitamin D deficiency and related complications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Ain Shams University | Conditions: Hemodialysis Complication, Vitamin D Deficiency | Phase 2, Phase 3 | Status: COMPLETED